Abstract:We recently found that overexpression of angiotensin (Ang)-converting enzyme 2 (ACE2) ameliorated cardiac remodeling and dysfunction induced by diabetes or acute myocardial infarction (AMI) in rats, accompanied by down-regulated Ang-II and up-regulated Ang-(1–7) expression [ 1 Dong B. Yu Q.T. Dai H.Y. et al. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. J Am Coll Cardiol. 2012; 59: 739-747 Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar , 2 Zhao Y.X. Yin H.Q. Yu Q.T. et al. ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Hum Gene Ther. 2010; 21: 1545-1554 Crossref PubMed Scopus (68) Google Scholar ]; and, Ang-(1–7) had similar effects in other animal models [ 3 Marques F.D. Ferreira A.J. Sinisterra R.D. et al. An oral formulation of angiotensin-(1–7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension. 2011; 57: 477-483 Crossref PubMed Scopus (105) Google Scholar , 4 Liu E. Xu Z. Li J. Yang S. Yang W. Li G. Enalapril, irbesartan, and angiotensin-(1–7) prevent atrial tachycardia-induced ionic remodeling. Int J Cardiol. 2011; 146: 364-370 Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar , 5 Li Y. Li G. Liu T. Angiotensin-(1–7): a new therapeutic strategy in the management of atrial fibrillation. Int J Cardiol. 2011; 147: 287-288 Abstract Full Text Full Text PDF PubMed Scopus (1) Google Scholar ]. Ohtsuki and colleagues reported that ACE2 gene expression was associated with left-ventricular remodeling in patients with end-stage heart failure [ [6] Ohtsuki M. Morimoto S. Izawa H. et al. Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure. Int J Cardiol. 2010; 145: 333-334 Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar ]. Moreover, plasma ACE2 activity has been reported to be associated with severity of myocardial dysfunction and be an independent predictor of adverse clinical events [ [7] Lehmann H.I. Wolke C. Malenke W. et al. Enzymatic activity of DPIV and renin–angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD). Int J Cardiol. Oct 10 2012; https://doi.org/10.1016/j.ijcard.2012.09.083 Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar ]. However, the relation between plasma Ang-(1–7) levels and cardiac remodeling after AMI is poorly understood. Thus, we examined the association of plasma Ang-(1–7) levels and myocardial damage and function after successful reperfusion therapy in patients with AMI by univariate and multivariate analyses.

Angiotensin (1-7) Alleviates Postresuscitation Myocardial Dysfunction by Suppressing Oxidative Stress Through the Phosphoinositide 3-Kinase, Protein Kinase B, and Endothelial Nitric Oxide Synthase Signaling Pathway

Ang (1-7) Improves Cardiac Function After Resuscitation From Cardiac Arrest

Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism

Angiotensin1-7 Protects Cardiomyocytes from Hypoxia/reoxygenation-Induced Oxidative Stress by Preventing ROS-associated Mitochondrial Dysfunction and Activating the Akt Signaling Pathway.

Erythropoietin Alleviates Post-Resuscitation Myocardial Dysfunction in Rats Potentially Through Increasing the Expression of Angiotensin II Receptor Type 2 in Myocardial Tissues

The Effects of Α- and Β-Adrenergic Blocking Agents on Postresuscitation Myocardial Dysfunction and Myocardial Tissue Injury in a Rat Model of Cardiac Arrest.

Angiotensin (1−7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice

Preconditioning but Not Postconditioning Treatment with Resveratrol Substantially Ameliorates Post‑resuscitation Myocardial Dysfunction Through the PI3K/Akt Signaling Pathway.

Prolylcarboxypeptidase Mitigates Myocardial Ischemia/Reperfusion Injury by Stabilizing Mitophagy

Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.

Usefulness of Angiotensin-(1–7) to Predict Myocardial Salvage after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction

Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors

Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats.

Inhibition of Nitrosative Stress Attenuates Myocardial Injury and Improves Outcomes after Cardiac Arrest and Resuscitation

Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion-induced injury through the inhibition of oxidative stress.

Ruthenium red alleviates post-resuscitation myocardial dysfunction by upregulating mitophagy through inhibition of USP33 in a cardiac arrest rat model

The ACE2/Ang-(1-7)/MasR axis alleviates brain injury after cardiopulmonary resuscitation in rabbits by activating PI3K/Akt signaling

Effects of ACE 2-Ang ( 1-7 )-Mas axis on primary myocardial cell apoptosis : an in vitro study

Abstract 11029: Netrin-1 Alleviates Post-Resuscitation Myocardial Dysfunction in a Rat Model of Cardiac Arrest

[Effects and Mechanisms of Heme Oxygenase-1 on Rats with Postresuscitation Myocardial Dysfunction].

Neuroprotective Effect of Angiotensin-(1-7) Against Focal Cerebral Ischemic-Reperfusion Injury in Rats